U.S. private equity firm Bain Capital has bought Mitsubishi Tanabe Pharma in a deal worth 510 billion yen ($3.4 billion), ...
The Japanese chemical company has agreed to sell its pharmaceutical business to Bain Capital for more than $3 billion, in a ...
Mitsubishi UFJ Financial Group's dividend yield and buyback program boost value. Learn why MUFG stock is a solid investment ...
11hon MSN
With EV sales growth slowing and threats by President Trump to impose tariffs, pause infrastructure buildout and end federal ...
The investment firm is acquiring Mitsubishi Tanabe Pharma in a deal valued at $3.3 billion. Elsewhere, Bausch + Lomb hasn’t ...
14h
Power Technology on MSNMitsubishi takes $342.4m impairment charge on domestic offshore windMitsubishi Corp has recorded an impairment charge of Y52.2bn ($342.4m) on its offshore wind projects in Japan.
Honda and Nissan shook the automotive industry in December 2024 with their announcement of a historic $58 billion merger plan ...
14h
PhilStar Global on MSNMitsubishi to invest P7 billion in PhilippinesMitsubishi Motors Corp. (MMC) is planning to invest P7 billion in the Philippines in the next five years, Malacañang ...
9h
GlobalData on MSNBain Capital buys Mitsubishi Tanabe Pharma for $3.3bnBain Capital said its decision to buy Mitsubishi Tanabe is due to the “strong growth potential” of Japan’s healthcare ...
Following rumblings of a private equity bidding war late last year, Bain Capital has emer | Bain Capital is laying out 510 ...
15h
AutoGuide on MSNDon't Buy A 2025 Nissan Versa For $18,330, Do This Instead!The Nissan Versa is the cheapest new car you can buy in 2025.In the United States, the humble sedan starts at $18,330 with a ...
Bain Capital, a leading global private investment firm, today announced it has signed a definitive agreement to acquire Mitsubishi Tanabe Pharma Corporation ("Tanabe Pharma", "MTPC" or "the Company") ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results